July 02, 2025 FDA Approves Ready-to-Infuse Vancomycin Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis. Conexiant
June 30, 2025 AACR 2025: Use of ctDNA-Based Liquid Biopsy Assay in Resectable Colorectal Cancer The ASCO Post
June 10, 2025 Digital Histopathology and Automated Classification of Pediatric Sarcomas The ASCO Post
April 29, 2025 AACR 2025: Survival Outcomes May Improve When Treatment Is Guided by Using Both Tissue and Liquid Biopsies The ASCO Post
June 27, 2025 Best Practice Recommendations for Clinical Homologous Recombination Deficiency Testing The ASCO Post